| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_869620724535c26b3e814325a37a5104 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42 |
| filingDate |
2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17f84308fdbd7fc4f1dd0d263114b46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd3887e755046425a4f561fe22fec8fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e39ef50902d58702bc12437bd778cafd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a59a6fcb3bee4f7cae85691b20faab3b |
| publicationDate |
2011-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2298745-A1 |
| titleOfInvention |
Preparation method of rosuvastatin calcium and its intermediates |
| abstract |
.A preparation method of rosuvastatin calcium (Formula 1), which can be used for the production of medicament lowering the levels of LDL-cholesterol and triglycerides in vivo, is provided. Such preparation method is suitable for industrial production. Furthermore, the intermediate crystallines used in the preparation method are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2646420-A1 |
| priorityDate |
2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |